|
|
Automation, modular design, and real-time analytics are transforming cell and gene therapy manufacturing to unlock scalable, cost-effective production. Discover how these innovations are not only accelerating the path from development to commercialization but also ensuring that quality is never compromised. |
|
|
|
Across the cell therapy landscape, manufacturers are adopting intelligent automation strategies to accelerate development. Leveraging small, automated models during process development offers a cost-effective and flexible alternative to commercial-scale systems, enabling rapid, iterative optimization alongside process control and consistency. |
|
|
|
How AI tools are applied to cell therapy manufacturing depends on the response sought by the manufacturer, who may want to promote better cell growth or better understand the connection between manufacturing and patient response. AI can assist in answering those questions using clinical data and manufacturing data sets. |
|
|
|
Cell therapy manufacturing is a rapidly evolving field that presents new challenges. Creating a manufacturing roadmap can help your organization navigate through these challenges and act as a guide to automation implementation. This roadmap should be developed during the preclinical phase and will require ongoing refinement. |
|
|
|
Learn more about making the transition towards automation in cell and gene therapy manufacturing and how collaborative partnerships can assist in navigating this path. In this webinar, industry leaders discuss the limitations of a one-size-fits-all approach to cell therapy manufacturing, the need for tailored solutions, as well as recognize the associated high costs of investing in automation. |
|
|
|
Monocyte-derived immunotherapies provide a promising new outlook on cancer treatments, but there are challenges to monocyte isolation during manufacturing. Consider the data and performance of a fully automated, closed counterflow centrifuge system designed to produce an enriched monocyte population with high purity, recovery, and viability. |
|
|
|
|
Discover how to deliver tailored, GMP-compliant automation solutions to your cell therapy manufacturing, which can accelerate innovation from process development to scalable production. |
|
|
